Quote · The Peter Attia Drive
#395 - Brain lipidology: understanding APOE, cholesterol homeostasis, Alzheimer's disease risk, and the effects of lipid-lowering therapies on brain health | Tom Dayspring, M.D.
Where this was said
APOE4, amyloid, and brain cholesterol pathology
At 59:50 · chapter starts 58:00
This is the mechanistic heart of the episode. Tom traces the full pathological chain: APOE4-carrying astrocytes produce an inferior ApoE4 protein that, when assembled into brain HDL particles, binds poorly to neuronal receptors (LDLR and LRP1). The result is decreased internalization of the cholesterol-laden particle. Instead of being fully taken into the lysosome where cholesterol can be liberated into the cytosol, the particle only deposits cholesterol onto the outer cell membrane — creating a paradox of membrane overload and cytosolic deficiency simultaneously [1] — Tom Dayspring "APOE4 produces inferior ApoE proteins that bind poorly to neuronal receptors, starving neurons of cholesterol. Without proper membrane chol…" 59:40 . With too much cholesterol in the neuronal cell membrane, beta and gamma secretases preferentially cleave amyloid precursor protein into amyloid-beta-42, the more toxic and aggregation-prone form [2] — Tom Dayspring "When neurons accumulate too much cholesterol, they convert it to 24S-hydroxycholesterol — a water-soluble form that can escape through the …" 1:04:10 . The proper ratio of cholesterol favors alpha-secretase cleavage into the less-toxic amyloid-beta-40. Tom also explains the neuron's cholesterol overflow mechanism: 24S-hydroxycholesterol, an oxysterol that is more water-soluble and can escape through the blood-brain barrier into plasma. Elevated plasma 24S-hydroxycholesterol signals active neuronal cholesterol overload — a biomarker researchers use to track Alzheimer's drug efficacy. Tom notes that statins have been shown to reduce these plasma levels, suggesting they may be correcting neuronal cholesterol excess.
APOE4 produces inferior ApoE proteins that bind poorly to neuronal receptors, starving neurons of cholesterol. Without proper membrane cholesterol, beta and gamma secretases cleave amyloid precursor protein into the toxic amyloid-beta-42 — the hallmark of Alzheimer's pathology.
Cholesterol in the brain has a half-life of approximately 5 years, compared to just a few days in peripheral tissues, reflecting the brain's extreme conservation of its cholesterol stores.
When neurons accumulate too much cholesterol, they convert it to 24S-hydroxycholesterol — a water-soluble form that can escape through the blood-brain barrier into plasma. Elevated levels in blood signal neuronal cholesterol overload and early neurodegeneration risk; statins reduce these levels.
Elevated plasma 24S-hydroxycholesterol signals that neurons are excreting excess cholesterol, indicating cholesterol overload and early neurodegeneration risk; statins have been shown to reduce these levels.
APOE4 brain HDL binds poorly to neuronal receptors, so instead of being internalized and releasing cholesterol into the cytosol, it only deposits cholesterol onto the cell membrane. The result is membrane overload and cytosolic deficiency simultaneously — a uniquely harmful double disruption.
